| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |